cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15468/dl.fyk453
title: Occurrence Download

description: A dataset containing 16 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Achnanthes Bory, 1822",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "BasisOfRecord is one of (Specimen, Living Specimen, Observation, Human Observation, Machine Observation, Material sample, Literature Occurrence, Material citation, Occurrence evidence)",
 "Geometry POLYGON ((15.6372 -28.0032,16.2782 -28.5786,20.509 -28.5786,20.509 -24.0715,15.4933 -24.0715,15.4945 -24.1257,16.0509 -25.6631,15.6372 -28.0032))"
 ]
}

 The dataset includes 16 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0038033-250525065834625/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.11192518
title: Hydraulic pump houses: 3D survey (Grotte di Castro, VT)

description: 3D Survey of the Hydraulic pump houses in the Municipality of Grotte di Castro (VT). The working group consists of: Emanuel Demetrescu, Eleonora Scopinaro, and Simone Berto.
DOI: 10.5281/zenodo.15647004
title: Hydraulic pump houses: 3D survey (Grotte di Castro, VT)

description: 3D Survey of the Hydraulic pump houses in the Municipality of Grotte di Castro (VT). The working group consists of: Emanuel Demetrescu, Eleonora Scopinaro, and Simone Berto.
DOI: 10.6084/m9.figshare.29255384
title: Krause et al. (2025) Global Change Biology

description: This dataset includes LPJ-GUESS outputs, the scripts to produce the Figures, and the LPJ-GUESS code including lightning mortality. The outputs from the two global LPJ-GUESS simulations (driven by LIS/OTD-EMAC and ENTLN lightning densities) are in LPJ-GUESS_global_LISOTD and LPJ-GUESS_global_ENTLN, respectively. The five simulations for the BCI forest are in LPJ-GUESS_Panama, the simulations for the US sites and the two Amazon sites in LPJ-GUESS_US_Amazon and the simulation for the Uganda site in LPJ-GUESS_Uganda. A description of LPJ-GUESS output files can be found in Summary.txt. The R scripts to produce the Figures are in R_scripts. The LPJ-GUESS code is in LPJ-GUESS_lightning.zip.
DOI: 10.6084/m9.figshare.29255384.v1
title: Krause et al. (2025) Global Change Biology

description: This dataset includes LPJ-GUESS outputs, the scripts to produce the Figures, and the LPJ-GUESS code including lightning mortality. The outputs from the two global LPJ-GUESS simulations (driven by LIS/OTD-EMAC and ENTLN lightning densities) are in LPJ-GUESS_global_LISOTD and LPJ-GUESS_global_ENTLN, respectively. The five simulations for the BCI forest are in LPJ-GUESS_Panama, the simulations for the US sites and the two Amazon sites in LPJ-GUESS_US_Amazon and the simulation for the Uganda site in LPJ-GUESS_Uganda. A description of LPJ-GUESS output files can be found in Summary.txt. The R scripts to produce the Figures are in R_scripts. The LPJ-GUESS code is in LPJ-GUESS_lightning.zip.
DOI: 10.57760/sciencedb.26186
title: Vedanga Jyotisa - Duration of the day Calculations
title: Vedanga Jyotisa - Duration of the day Calculations

description: The data contains the comparison of the Duration of days in a given year (starting from 21st March 2024). Analysis is done to compare the actual duration with the durations mention in older texts.
description: The data contains the comparison of the Duration of days in a given year (starting from 21st March 2024). Analysis is done to compare the actual duration with the durations mention in older texts.
DOI: 10.57760/sciencedb.26176
title: Online bipartite matching methodology for resources with major epidemics: adaptive time window based on reinforcement learning
title: Online bipartite matching methodology for resources with major epidemics: adaptive time window based on reinforcement learning

description: This paper studies online matching problem of anti-epidemic resources between demanders and suppliers on the Internet of healthcare systems in a major outbreak, considering the heterogeneity of suppliers and demanders respectively. A time-window-based multi-stage online dynamic bipartite matching model is formulated, which can be transformed into a Markov decision process. The paper proposes adaptive time window batch bipartite matching algorithm based on reinforcement learning with nearest neighbor first heuristic strategy to allocate anti-epidemic resources. The findings indicate that while the matching rate continues to rise, the average waiting time exhibits a tendency of first reducing and then increasing as the matching time window gets longer. This implies that a manager should adjust the matching time window in accordance with the epidemic's development tendency and the availability of resources. It demonstrates that keep exploring the matching time window at a high level with taking the acceptable waiting time into account.
description: This paper studies online matching problem of anti-epidemic resources between demanders and suppliers on the Internet of healthcare systems in a major outbreak, considering the heterogeneity of suppliers and demanders respectively. A time-window-based multi-stage online dynamic bipartite matching model is formulated, which can be transformed into a Markov decision process. The paper proposes adaptive time window batch bipartite matching algorithm based on reinforcement learning with nearest neighbor first heuristic strategy to allocate anti-epidemic resources. The findings indicate that while the matching rate continues to rise, the average waiting time exhibits a tendency of first reducing and then increasing as the matching time window gets longer. This implies that a manager should adjust the matching time window in accordance with the epidemic's development tendency and the availability of resources. It demonstrates that keep exploring the matching time window at a high level with taking the acceptable waiting time into account.
DOI: 10.57760/sciencedb.26174
title: Roles of non-stoichiometric Mg2+-Si4+ co-doping in the sintering process of TAG ceramics with higher optical quality
title: 非化学计量比Mg-Si共掺杂在更高光学质量中的TAG陶瓷烧结中的作用

description: Compared with sintering aids added in a single traditional weight ratio, non-stoichiometric Mg2+-Si4+ co-doping in lattice site has been found to significantly enhance the optical quality of garnet transparent ceramics for solid-state laser systems by reducing grain boundary residues. However, its specific roles and mechanisms at different stages of ceramic sintering remain unclear. In this work, we systematically investigated the effects of non-stoichiometric Mg2+-Si4+ co-doping on the sintering process of TAG ceramics, revealing the solid-solution behavior of Mg/Si at different stages and its relationship with densification, phase evolution, and microstructure of grain boundary. Through analysis of lattice parameter and Oxygen vacancy concentration change, it was found that Si enters the lattice earlier than Mg, and as temperature increases, the presence of Si in turn enhances the solid solubility of Mg. By precisely controlling the Mg/Si doping ratio, optimized control of the densification process was achieved. TEM analysis of the optimal sample's grain boundaries showed that under high addition amounts of MgO and TEOS, the non-stoichiometric design method significantly reduced grain boundary residual phases. This discovery highlights the importance of synergistic optimisation of aids species and content under non-stoichiometric doping for preparing higher optical quality garnet transparent ceramics.
description: Compared with sintering aids added in a single traditional weight ratio, non-stoichiometric Mg2+-Si4+ co-doping in lattice site has been found to significantly enhance the optical quality of garnet transparent ceramics for solid-state laser systems by reducing grain boundary residues. However, its specific roles and mechanisms at different stages of ceramic sintering remain unclear. In this work, we systematically investigated the effects of non-stoichiometric Mg2+-Si4+ co-doping on the sintering process of TAG ceramics, revealing the solid-solution behavior of Mg/Si at different stages and its relationship with densification, phase evolution, and microstructure of grain boundary. Through analysis of lattice parameter and Oxygen vacancy concentration change, it was found that Si enters the lattice earlier than Mg, and as temperature increases, the presence of Si in turn enhances the solid solubility of Mg. By precisely controlling the Mg/Si doping ratio, optimized control of the densification process was achieved. TEM analysis of the optimal sample's grain boundaries showed that under high addition amounts of MgO and TEOS, the non-stoichiometric design method significantly reduced grain boundary residual phases. This discovery highlights the importance of synergistic optimisation of aids species and content under non-stoichiometric doping for preparing higher optical quality garnet transparent ceramics.
DOI: 10.57760/sciencedb.26170
title: Shengjiang Powder alleviates oxidative stress damage and fibrosis in mice with atherosclerosis concurrent with non-alcoholic fatty liver disease
title: Shengjiang Powder alleviates oxidative stress damage and fibrosis in mice with atherosclerosis concurrent with non-alcoholic fatty liver disease

description: Statistical analysis was performed using SPSS 26.0. Data are presented as mean ± standard deviation. For multiple groups with normally distributed data, one-way ANOVA was used for intergroup comparisons; otherwise, nonparametric tests were employed. A P-value &lt; 0.05 was considered statistically significant.
description: Statistical analysis was performed using SPSS 26.0. Data are presented as mean ± standard deviation. For multiple groups with normally distributed data, one-way ANOVA was used for intergroup comparisons; otherwise, nonparametric tests were employed. A P-value &lt; 0.05 was considered statistically significant.
DOI: 10.15468/dl.dfb562
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Achnanthes Bory, 1822",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "BasisOfRecord is one of (Specimen, Living Specimen, Observation, Human Observation, Machine Observation, Material sample, Literature Occurrence, Material citation, Occurrence evidence)",
 "Geometry POLYGON ((15.4784 -23.4046,15.4933 -24.0715,20.509 -24.0715,20.509 -24.0455,20.0952 -23.5072,19.9968 -23.017,19.7843 -22.5405,19.1988 -21.8785,18.5972 -21.5447,17.8859 -21.3993,17.1626 -21.4805,16.5332 -21.7596,16.1257 -22.0882,15.8234 -22.4662,15.606 -22.8993,15.4784 -23.4046))"
 ]
}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0038034-250525065834625/datasets/export for details.
DOI: 10.5281/zenodo.15647367
title: raebin
DOI: 10.5281/zenodo.15647368
title: raebin
DOI: 10.15468/dl.tm8vw8
title: Occurrence Download

description: A dataset containing 249254 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Chelonia mydas (Linnaeus, 1758)"
 ]
}

 The dataset includes 249254 records from 500 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0038023-250525065834625/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.3ejex8
title: Occurrence Download

description: A dataset containing 305 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is Portugal",
 "OccurrenceStatus is Present",
 "TaxonKey is Acrocephalus paludicola (Vieillot, 1817)"
 ]
}

 The dataset includes 305 records from 5 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0038035-250525065834625/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.64dcuw
title: Occurrence Download

description: A dataset containing 48 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Achnanthes Bory, 1822",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "BasisOfRecord is one of (Specimen, Living Specimen, Observation, Human Observation, Machine Observation, Material sample, Literature Occurrence, Material citation, Occurrence evidence)",
 "Geometry POLYGON ((25.5395 -28.5786,20.509 -28.5786,20.509 -32.9007,25.5395 -32.9007,25.5395 -28.5786))"
 ]
}

 The dataset includes 48 records from 2 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0038036-250525065834625/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.3q4zwh
title: Occurrence Download

description: A dataset containing 9019 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is Portugal",
 "OccurrenceStatus is Present",
 "TaxonKey is Sylvia borin (Boddaert, 1783)"
 ]
}

 The dataset includes 9019 records from 14 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0038037-250525065834625/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.fh599x
title: Occurrence Download

description: A dataset containing 7513 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is Portugal",
 "OccurrenceStatus is Present",
 "TaxonKey is Pyrrhocorax pyrrhocorax (Linnaeus, 1758)"
 ]
}

 The dataset includes 7513 records from 15 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0038039-250525065834625/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.9vf4y5
title: Occurrence Download

description: A dataset containing 2281 species occurrences available in GBIF matching the query:
{
 "and" : [
 "BasisOfRecord is one of (Observation, Human Observation, Machine Observation)",
 "Geometry POLYGON((-8.13297 38.52744,-5.54098 38.52744,-5.54098 42.30806,-8.13297 42.30806,-8.13297 38.52744))",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "OccurrenceStatus is Present",
 "TaxonKey is Cervus elaphus Linnaeus, 1758",
 "Year 2012-2025"
 ]
}

 The dataset includes 2281 records from 7 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0038038-250525065834625/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.29301998
title: Supplementary Material for: Safety profile of intravitreal Dexamethasone implant to manage diabetic macular edema: A systematic review of real-world studies.

description: Introduction: With increasing experience using intravitreal dexamethasone implant (DEX-i), it has become a first-line therapy in patients with diabetic macular edema (DME), due mainly to its good efficacy profile. However, this treatment is not devoid of adverse events, which are predominantly transient and should be considered when administering it. Methods: This systematic review without meta-analysis adhered to the guidelines delineated in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. Systematic electronic searches were conducted in the PubMed, Medline, Embase, and Google Scholar databases to identify real-world evidence (RWE) studies assessing the safety profile of DEX-i in patients with DME, covering the period from January 1, 2014, to March 1, 2024. Results: This review included Seventy-six RWE that evaluated the safety of DEX-i. Regarding intraocular pressure (IOP)-related adverse events (AEs), these AEs were very heterogeneous and have included different definitions. The incidence of IOP-related AEs varied significantly from study to study, from 2% to almost 60%. In general, the peak IOP increase was typically observed 60 days post-DEX-i injection, followed by a decrease in the subsequent months. In most patients, these IOP-related AEs were successfully and efficiently managed with topical IOP-lowering medication, although some patients required additional treatments (i.e., laser or surgery). Regarding cataract development rates, the results were conflicting, with some studies showing rates ≥40%, %, while others reported rates of 0% or less than 5%. Additionally, current evidence showed the beneficial effects of DEX-i in eyes with DME that underwent cataract surgery. Other serious ocular AEs related to DEX-i were rare, indeed, the reported-incidence-rate of endophthalmitis ranged between 0.07%-0.3%. Conclusions: Overall, the main DEX-i-related AEs were elevation of IOP and cataract. Episodes of ocular hypertension were usually transient and successfully controlled with topical treatment. Additionally, repeated treatment with DEX-i in the same eye was not associated with IOP-related AEs, but it was with cataract-related AEs.
DOI: 10.6084/m9.figshare.29301998.v1
title: Supplementary Material for: Safety profile of intravitreal Dexamethasone implant to manage diabetic macular edema: A systematic review of real-world studies.

description: Introduction: With increasing experience using intravitreal dexamethasone implant (DEX-i), it has become a first-line therapy in patients with diabetic macular edema (DME), due mainly to its good efficacy profile. However, this treatment is not devoid of adverse events, which are predominantly transient and should be considered when administering it. Methods: This systematic review without meta-analysis adhered to the guidelines delineated in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. Systematic electronic searches were conducted in the PubMed, Medline, Embase, and Google Scholar databases to identify real-world evidence (RWE) studies assessing the safety profile of DEX-i in patients with DME, covering the period from January 1, 2014, to March 1, 2024. Results: This review included Seventy-six RWE that evaluated the safety of DEX-i. Regarding intraocular pressure (IOP)-related adverse events (AEs), these AEs were very heterogeneous and have included different definitions. The incidence of IOP-related AEs varied significantly from study to study, from 2% to almost 60%. In general, the peak IOP increase was typically observed 60 days post-DEX-i injection, followed by a decrease in the subsequent months. In most patients, these IOP-related AEs were successfully and efficiently managed with topical IOP-lowering medication, although some patients required additional treatments (i.e., laser or surgery). Regarding cataract development rates, the results were conflicting, with some studies showing rates ≥40%, %, while others reported rates of 0% or less than 5%. Additionally, current evidence showed the beneficial effects of DEX-i in eyes with DME that underwent cataract surgery. Other serious ocular AEs related to DEX-i were rare, indeed, the reported-incidence-rate of endophthalmitis ranged between 0.07%-0.3%. Conclusions: Overall, the main DEX-i-related AEs were elevation of IOP and cataract. Episodes of ocular hypertension were usually transient and successfully controlled with topical treatment. Additionally, repeated treatment with DEX-i in the same eye was not associated with IOP-related AEs, but it was with cataract-related AEs.
DOI: 10.15468/dl.u629fp
title: Occurrence Download

description: A dataset containing 12 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Achnanthes Bory, 1822",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "BasisOfRecord is one of (Specimen, Living Specimen, Observation, Human Observation, Machine Observation, Material sample, Literature Occurrence, Material citation, Occurrence evidence)",
 "Geometry POLYGON ((20.7576 -24.3688,20.529 -24.0715,20.509 -24.0715,20.509 -28.5786,25.5395 -28.5786,25.5395 -24.0715,25.1306 -24.0715,24.9333 -24.4571,23.8962 -24.2467,22.8065 -24.295,22.3719 -24.7207,22.2323 -25.547,22.0387 -25.7188,21.7833 -25.7784,21.5388 -25.7113,21.3553 -25.5415,20.7576 -24.3688))"
 ]
}

 The dataset includes 12 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0038040-250525065834625/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.29302001
title: Supplementary Material for: The risk of cardiovascular disease following aromatase inhibitor therapy for breast cancer in postmenopausal women: a systematic review and meta-analysis

description: Background
More women are recovering and living longer lives due to advancement in breast cancer therapies. Aromatase inhibitors (AI) are one form of endocrine therapy for breast cancer that may have an impact on the risk of developing cardiovascular diseases later in life. This study investigated whether aromatase inhibitors therapy for breast cancer in postmenopausal women increase the risk of developing cardiovascular disease in comparison with tamoxifen therapy or no hormonal therapy.
Methods
Comparisons were made between tamoxifen and no hormonal therapy. We searched publicly available databases for studies including postmenopausal women who underwent AI therapy for breast cancer investigating the risk ratio of specific cardiovascular outcomes and cardiovascular death. 
Results
There was a significant increase in the risk of ischaemic heart disease (RR 1.59, 95% CI: 1.25-2.02, p&lt;0.05), myocardial infarction (RR 1.50, 95% CI: 1.13-1.99, p&lt;0.05), heart failure (RR 1.63, 95% CI: 1.14-2.32, p&lt;0.05) and other cardiovascular events (RR 1.26, 95% CI: 1.12-1.40, p&lt;0.05) in the AI group when compared to tamoxifen. However, there was a significant decrease in the risk of myocardial infarction (RR 0.77, 95% CI: 0.65-0.90, p&lt;0.05) in the AI group when compared to no hormonal treatment.
Conclusion
There is an increased risk of cardiovascular disease for AI therapy in comparison to tamoxifen therapy, but the risk is not elevated when compared to those receiving no hormonal treatment.
Implications for Cancer Survivors
Prognosis and survival of patients should be an important consideration in choosing between tamoxifen and AI therapy among patients receiving treatment for breast cancer.